SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-099567
Filing Date
2020-04-06
Accepted
2020-04-06 16:47:40
Documents
6
Effectiveness Date
2020-04-06

Document Format Files

Seq Description Document Type Size
1 DEFA14A d914415ddefa14a.htm DEFA14A 19443
2 GRAPHIC g914415g86v94.jpg GRAPHIC 65272
3 GRAPHIC g914415pc1.jpg GRAPHIC 135358
4 GRAPHIC g914415pc2.jpg GRAPHIC 181495
5 GRAPHIC g914415pc3.jpg GRAPHIC 56233
6 GRAPHIC g914415pc4.jpg GRAPHIC 14660
  Complete submission text file 0001193125-20-099567.txt   605961
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-06571 | Film No.: 20777472
SIC: 2834 Pharmaceutical Preparations